Humana Inc. (HUM) Receives Equal Weight Rating from Barclays PLC
Humana Inc. (NYSE:HUM)‘s stock had its “equal weight” rating restated by equities researchers at Barclays PLC in a research report issued to clients and investors on Friday. They currently have a $191.00 target price on the insurance provider’s stock. Barclays PLC’s target price would suggest a potential upside of 12.70% from the stock’s current price.
Several other research firms also recently issued reports on HUM. Leerink Swann restated an “outperform” rating on shares of Humana in a research report on Tuesday, June 21st. Credit Suisse Group AG restated a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. Argus restated a “hold” rating on shares of Humana in a research report on Tuesday, August 23rd. Cantor Fitzgerald reiterated a “buy” rating on shares of Humana in a research report on Monday, August 8th. Finally, Wolfe Research started coverage on Humana in a research report on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $200.50.
Shares of Humana (NYSE:HUM) opened at 169.48 on Friday. The company’s 50-day moving average price is $176.12 and its 200-day moving average price is $175.83. The company has a market cap of $25.26 billion, a price-to-earnings ratio of 26.04 and a beta of 0.90. Humana has a 12 month low of $150.00 and a 12 month high of $191.65.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.07. The firm had revenue of $14 billion for the quarter, compared to the consensus estimate of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business’s quarterly revenue was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.67 earnings per share. Analysts anticipate that Humana will post $9.24 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be issued a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.68%. Humana’s dividend payout ratio is currently 18.18%.
A number of hedge funds have recently modified their holdings of HUM. Point72 Asia Hong Kong Ltd bought a new stake in shares of Humana during the second quarter valued at approximately $126,000. Daiwa SB Investments Ltd. raised its stake in shares of Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares during the period. Bessemer Group Inc. raised its stake in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares during the period. Fulton Bank N.A. bought a new stake in shares of Humana during the third quarter valued at approximately $229,000. Finally, BB&T Securities LLC raised its stake in shares of Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock valued at $247,000 after buying an additional 165 shares during the period. Institutional investors and hedge funds own 93.24% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.